课题基金 / 基金详情

Screening for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias

Screening for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias
筛选针对 MLL 相关白血病中 Menin-MLL 相互作用的抑制剂
批准号：
9205799
负责人：
Noel Southall
金额：
$11.4万
依托单位：
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/9205799
关键词：
ScreeningInhibitorsTargetingMeninMLL

项目摘要

项目成果

Noel Southall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of substances that change alternative pre-mRNA splicing of the serotonin 2C receptor
Inhibitors of Cell Surface uPA Generation
Malaria Phosphatase Inhibitors Identified as a Potential New Malaria Treatment
Development of small molecule agonists of the parathyroid hormone receptor type-1 (PTHR1) as potential new therapeutics for the treatment of osteoporosis
海外基金